Filing Details
- Accession Number:
- 0001209191-22-034895
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-07 18:17:08
- Reporting Period:
- 2022-06-03
- Accepted Time:
- 2022-06-07 18:17:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1538210 | Neximmune Inc. | NEXI | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1843817 | Grant Verstandig | C/O Neximmune, Inc. 9119 Gaither Road Gaithersburg MD 20877 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-07 | 26,876 | $2.28 | 1,105,495 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-06 | 25,000 | $2.14 | 1,078,619 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-03 | 15,000 | $2.22 | 1,053,619 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.14 to $2.45, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- Excludes 17,376 shares of common stock underlying options that are currently exercisable.
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.06 to $2.28, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.13 to $2.30, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
